Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions.
Lynch KN, Liu JF, Kesten N, Chow KH, Shetty A, He R, Afreen MF, Yuan L, Matulonis UA, Growdon WB, Muto MG, Horowitz NS, Feltmate CM, Worley MJ Jr, Berkowitz RS, Crum CP, Rueda BR, Hill SJ.
Lynch KN, et al. Among authors: afreen mf.
Cancers (Basel). 2021 May 3;13(9):2195. doi: 10.3390/cancers13092195.
Cancers (Basel). 2021.
PMID: 34063609
Free PMC article.